Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Decaens

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
The Lancet. Microbe|March 5, 2026
Invasive aspergillosis in liver transplant recipients in France (2007-21): a nationwide, retrospective, matched case-control studyCoralie Le Hyaric, Cléa Melenotte, François Lefebvre, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2026
Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF CohortMarie Decraecker, Héloïse Bourien, Elhadji Malick Thiam, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Nature|April 16, 2010
International network of cancer genome projects, Thomas J Hudson, Warwick Anderson, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
The Lancet. Microbe|March 5, 2026
Invasive aspergillosis in liver transplant recipients in France (2007-21): a nationwide, retrospective, matched case-control studyCoralie Le Hyaric, Cléa Melenotte, François Lefebvre, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2026
Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF CohortMarie Decraecker, Héloïse Bourien, Elhadji Malick Thiam, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Nature|April 16, 2010
International network of cancer genome projects, Thomas J Hudson, Warwick Anderson, et al.
Pageof 13